Most Viewed Posts Clear Filters Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested 2 February 2018 The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis 6 June 2018 Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model 25 January 2019 Clear Filters Alzheimer28 May 2026 Montpellier: Regenlife sheds light on the fight against Alzheimer’s disease Alzheimer28 May 2026 A helmet and a belt to slow the progression of Alzheimer’s disease: an ingenious idea being tested at the Hospices Civils de Lyon Alzheimer1 April 2026 Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes Alzheimer Concussions16 March 2026 IN THE SPOTLIGHT – REGEnLIFE: At the crossroads of medicine and physics – Pharmaceutiques Magazine No. 335 / March 2026 Alzheimer Depression Multiple sclerosis15 March 2026 Can Light Heal the Brain? REGEnLIFE Explores Photobiomodulation for Alzheimer’s
